...
首页> 外文期刊>Journal of Translational Medicine >The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension
【24h】

The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension

机译:肥大细胞整合了门脉高压症的内脏和全身炎症反应

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Portal hypertension is a clinical syndrome that is difficult to study in an isolated manner since it is always associated with a greater or lesser degree of liver functional impairment. The aim of this review is to integrate the complications related to chronic liver disease by using both, the array of mast cell functions and mediators, since they possibly are involved in the pathophysiological mechanisms of these complications. The portal vein ligated rat is the experimental model most widely used to study this syndrome and it has been considered that a systemic inflammatory response is produced. This response is mediated among other inflammatory cells by mast cells and it evolves in three linked pathological functional systems. The nervous functional system presents ischemia-reperfusion and edema (oxidative stress) and would be responsible for hyperdynamic circulation; the immune functional system causes tissue infiltration by inflammatory cells, particularly mast cells and bacteria (enzymatic stress) and the endocrine functional system presents endothelial proliferation (antioxidative and antienzymatic stress) and angiogenesis. Mast cells could develop a key role in the expression of these three phenotypes because their mediators have the ability to produce all the aforementioned alterations, both at the splanchnic level (portal hypertensive enteropathy, mesenteric adenitis, liver steatosis) and the systemic level (portal hypertensive encephalopathy). This hypothetical splanchnic and systemic inflammatory response would be aggravated during the progression of the chronic liver disease, since the antioxidant ability of the body decreases. Thus, a critical state is produced, in which the appearance of noxious factors would favor the development of a dedifferentiation process protagonized by the nervous functional system. This system rapidly induces an ischemia-reperfusion phenotype with hydration and salinization of the body (hepatorenal syndrome, ascites) which, in turn would reduce the metabolic needs of the body and facilitate its temporary survival.
机译:门静脉高压症是一种临床症状,很难以孤立的方式进行研究,因为它总是与或多或少的肝功能损害程度相关。这篇综述的目的是通过同时使用肥大细胞功能和介导物来整合与慢性肝病相关的并发症,因为它们可能与这些并发症的病理生理机制有关。门静脉结扎大鼠是最广泛用于研究该综合征的实验模型,并且已经认为会产生全身性炎症反应。该反应在肥大细胞中介导于其他炎症细胞中,并在三个相关的病理功能系统中进化。神经功能系统呈现局部缺血-再灌注和水肿(氧化应激),并可能导致高动力循环。免疫功能系统导致组织被炎性细胞(尤其是肥大细胞和细菌)浸润(酶促应激),而内分泌功能系统呈现内皮增生(抗氧化和抗酶促应激)和血管生成。肥大细胞可能在这三种表型的表达中发挥关键作用,因为它们的介体具有在内脏水平(门静脉高压性肠病,肠系膜腺炎,肝脂肪变性)和全身性水平(门静脉高压性)产生所有上述改变的能力。脑病)。由于身体的抗氧化能力下降,这种假设的内脏和全身性炎症反应在慢性肝病的进展过程中会加重。因此,产生了临界状态,其中有害因素的出现将有利于神经功能系统所致的去分化过程的发展。该系统迅速诱导出体内水合作用和盐碱化(肝肾综合征,腹水)的局部缺血-再灌注表型,进而降低了人体的代谢需求并促进其暂时存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号